Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare REITs Industry Analysis

UpdatedMay 31, 2026
DataAggregated Company Financials
Companies19
  • 7D-3.9%
  • 3M-2.0%
  • 1Y26.9%
  • YTDn/a

Over the last 7 days, the Healthcare REITs industry has dropped 3.9%, driven by Welltower declining 5.0%. Over the past 12 months, the industry was up 27%. Looking forward, earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the U.S. Healthcare REITs Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 01 Jun 2026US$275.9bUS$34.7bUS$1.6b38.4x170.7x8x
Wed, 29 Apr 2026US$274.4bUS$33.3bUS$741.2m51x370.2x8.2x
Fri, 27 Mar 2026US$252.5bUS$32.5bUS$355.1m35.3x710.9x7.8x
Sun, 22 Feb 2026US$266.7bUS$32.7bUS$172.2m45.7x1548.5x8.2x
Tue, 20 Jan 2026US$246.7bUS$31.5bUS$440.3m33x560.3x7.8x
Thu, 18 Dec 2025US$240.8bUS$31.5bUS$440.3m33x546.9x7.7x
Sat, 15 Nov 2025US$243.1bUS$31.5bUS$433.2m31.9x561.2x7.7x
Mon, 13 Oct 2025US$217.3bUS$30.4bUS$354.3m30.2x613.4x7.1x
Wed, 10 Sep 2025US$223.7bUS$30.4bUS$354.3m33.2x631.4x7.4x
Fri, 08 Aug 2025US$217.1bUS$30.8bUS$266.5m34x814.7x7x
Sun, 06 Jul 2025US$200.6bUS$29.4bUS$68.9m37x2911.3x6.8x
Tue, 03 Jun 2025US$199.2bUS$29.7bUS$181.8m32x1095.3x6.7x
Thu, 01 May 2025US$199.7bUS$29.4b-US$1,082,546,000.0033.5x-184.5x6.8x
Sat, 29 Mar 2025US$202.1bUS$28.7b-US$1,068,162,000.0035x-189.2x7x
Mon, 24 Feb 2025US$196.2bUS$28.1b-US$1,436,327,000.0033.7x-136.6x7x
Wed, 22 Jan 2025US$179.3bUS$27.4b-US$1,625,663,000.0041.5x-110.3x6.6x
Fri, 20 Dec 2024US$175.7bUS$27.4b-US$1,625,663,000.0040.7x-108.1x6.4x
Sun, 17 Nov 2024US$189.1bUS$27.4b-US$1,625,662,000.0044.3x-116.3x6.9x
Tue, 15 Oct 2024US$182.3bUS$26.2b-US$1,429,354,000.0053.7x-127.6x7x
Thu, 12 Sep 2024US$184.9bUS$26.2b-US$1,429,354,000.0053.9x-129.4x7.1x
Sat, 10 Aug 2024US$169.2bUS$26.6b-US$1,382,176,000.0051x-122.4x6.4x
Mon, 08 Jul 2024US$155.4bUS$26.1b-US$1,195,454,000.0044.6x-130x6x
Wed, 05 Jun 2024US$152.7bUS$26.1b-US$1,195,454,000.0042.2x-127.7x5.9x
Fri, 03 May 2024US$120.1bUS$23.1b-US$315,722,000.0041.8x-380.3x5.2x
Sun, 31 Mar 2024US$117.7bUS$22.6b-US$276,709,000.0041.8x-425.3x5.2x
Tue, 27 Feb 2024US$113.6bUS$23.0b-US$277,711,000.0035.1x-409.1x4.9x
Thu, 25 Jan 2024US$115.0bUS$24.3bUS$48.6m43.7x2366.3x4.7x
Sat, 23 Dec 2023US$118.8bUS$24.3bUS$48.6m46.4x2445.4x4.9x
Mon, 20 Nov 2023US$111.2bUS$24.3bUS$48.6m39.9x2289.7x4.6x
Wed, 18 Oct 2023US$109.0bUS$23.9bUS$463.1m29.4x235.5x4.6x
Fri, 15 Sep 2023US$108.5bUS$24.0bUS$472.6m33.5x229.5x4.5x
Sun, 13 Aug 2023US$113.3bUS$23.9bUS$531.9m35.3x213x4.7x
Tue, 11 Jul 2023US$110.8bUS$23.3bUS$746.1m32.7x148.6x4.7x
Thu, 08 Jun 2023US$109.2bUS$23.3bUS$819.6m29.9x133.3x4.7x
Price to Earnings Ratio

133.3x


Total Market Cap: US$109.2bTotal Earnings: US$819.6mTotal Revenue: US$23.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare REITs Industry Price to Earnings3Y Average 372.3x202420252026
Current Industry PE
  • Investors are pessimistic on the American Health Care REITs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 171x which is lower than its 3-year average PE of 372x.
  • The 3-year average PS ratio of 6.4x is lower than the industry's current PS ratio of 8.0x.
Past Earnings Growth
  • The earnings for companies in the Health Care REITs industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 14% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Healthcare REITs compare with similar industries?

US Market1.58%
Real Estate-1.15%
REITS-0.43%
Healthcare REITs-3.85%
Hotel and Resort REITs2.70%
Office REITs1.66%
Retail REITs-0.33%
Diversified REITs-0.43%
Industrial REITs-0.86%
Specialized REITs-1.09%
Residential REITs-1.64%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ARE Alexandria Real Estate EquitiesUS$49.682.7%
+US$228.3m		-29.2%PB0.6x
MPT Medical Properties TrustUS$5.110.6%
+US$17.9m		11.8%PB0.7x
JAN Janus LivingUS$26.770.2%
+US$9.4m		n/aPB2.3x
SILA Sila Realty TrustUS$30.240.1%
+US$1.7m		21.3%PB1.3x

Latest News

DOC
US$19.15
Healthpeak Properties
7D
-2.9%
1Y
10.0%
MPT
US$5.11
Medical Properties Trust
7D
0.6%
1Y
11.8%
VTR
US$84.42
Ventas
7D
-4.3%
1Y
31.3%
Narrative Update • May 29

VTR: Improved 2026 Earnings Outlook Will Support Bullish Cash Flow Trajectory

Analysts have lifted their price target on Ventas from $93.10 to $96.65 as they update their assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Ventas updated full year 2026 guidance for attributable net income per share to a range of $0.56 to $0.63, with a midpoint of $0.60, compared with the prior midpoint of $0.57 (company guidance).
ARE
US$49.68
Alexandria Real Estate Equities
7D
2.7%
1Y
-29.2%
HR
US$19.92
Healthcare Realty Trust
7D
-2.2%
1Y
37.4%
Narrative Update • May 25

HR: Share Repurchases And Margin Assumptions Will Shape Balanced Future Outlook

Analysts have raised their price target for Healthcare Realty Trust from about $19.64 to $20.45, citing updated assumptions that combine a slightly lower discount rate and P/E multiple with revised expectations for revenue growth and profit margins. What's in the News Healthcare Realty Trust reaffirmed its 2026 earnings guidance, with expected earnings per share in a range of a loss of $0.05 to a gain of $0.05, in line with prior guidance (Company guidance).
WELL
US$205.33
Welltower
7D
-5.0%
1Y
33.1%
OHI
US$46.76
Omega Healthcare Investors
7D
-2.4%
1Y
26.4%
AHR
US$48.89
American Healthcare REIT
7D
-2.6%
1Y
39.9%
NHI
US$73.29
National Health Investors
7D
-4.1%
1Y
1.1%
SBRA
US$19.89
Sabra Health Care REIT
7D
-4.0%
1Y
13.8%
Seeking Alpha • May 17

Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth

Summary Sabra Health Care REIT is rated a buy, reflecting portfolio growth, reasonable valuation, and robust geographic diversification. SBRA demonstrates strong revenue and NOI growth but faces declining EBITDA margins and flat long-term dividend growth, tempering its income appeal. The REIT maintains an investment-grade balance sheet, modest debt-to-equity, low operator concentration, and adequate AFFO dividend coverage with a 5.6% yield. Technical momentum remains bullish, with an +8% upside forecast by 2027, though sector risks include rising labor costs and potential shifts toward home healthcare. Read the full article on Seeking Alpha
SILA
US$30.24
Sila Realty Trust
7D
0.1%
1Y
21.3%
JAN
US$26.77
Janus Living
7D
0.2%
1Y
n/a